The House will try again next week to pass a Republican bill to help fatally ill people try unproven treatments — and supporters seem likely to prevail.
The House rejected the measure Tuesday, even though the vote was 259-140 for the legislation. It lost because GOP leaders used a procedure normally reserved for uncontroversial bills that requires a two-thirds majority for passage. Tuesday’s vote fell just short of that margin.
Continue Reading Below
Under the measure, the Food and Drug Administration would no longer have to sign off if a doctor and a drug manufacturer agree to let a patient try a pharmaceutical that’s not yet been approved by the federal agency.
Democrats say the measure is unnecessary because under an existing program, the FDA already approves 99 percent of such requests.
